Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury
- PMID: 18713872
- PMCID: PMC2614594
- DOI: 10.1189/jlb.0308173
Identification and characterization of infiltrating macrophages in acetaminophen-induced liver injury
Abstract
The role of macrophages in the pathogenesis of acetaminophen (APAP)-induced liver injury remains controversial, as it has been demonstrated that these cells display pro-toxicant and hepato-protective functions. This controversy may stem from the heterogeneity and/or plasticity of macrophages and the difficulty in distinguishing and differentially studying subpopulations of macrophages in the liver. In the present study, using flow cytometric analysis and fluorescence-labeled antibodies against specific cell surface macrophage markers, we were able to, for the first time, identify an APAP-induced macrophage (IM) population distinct from resident Kupffer cells. The data demonstrated that the IMs were derived from circulating monocytes that infiltrated the liver following APAP-induced liver injury. The IMs exhibited a phenotype consistent with that of alternatively activated macrophages and demonstrated the ability to phagocytize apoptotic cells and induce apoptosis of neutrophils. Furthermore, in the absence of the IMs, the resolution of hepatic damage following APAP-induced hepatotoxicity was delayed in CCR2(-/-) mice compared with wild-type mice. These findings likely contribute to the role of the IMs in the processes of tissue repair, including counteracting inflammation and promoting angiogenesis. The present study also demonstrated the ability of separating populations of macrophages and delineating distinct functions of each group in future studies of inflammatory disease in the liver and other tissues.
Figures
Similar articles
-
Chemokine (C-C motif) receptor 2-positive monocytes aggravate the early phase of acetaminophen-induced acute liver injury.Hepatology. 2016 Nov;64(5):1667-1682. doi: 10.1002/hep.28682. Epub 2016 Jul 22. Hepatology. 2016. PMID: 27302828
-
Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse.Hepatology. 2002 May;35(5):1093-103. doi: 10.1053/jhep.2002.33162. Hepatology. 2002. PMID: 11981759
-
Role of hepatic resident and infiltrating macrophages in liver repair after acute injury.Biochem Pharmacol. 2013 Sep 15;86(6):836-43. doi: 10.1016/j.bcp.2013.07.006. Epub 2013 Jul 19. Biochem Pharmacol. 2013. PMID: 23876342 Free PMC article.
-
Autophagy and acetaminophen-induced hepatotoxicity.Arch Toxicol. 2018 Jul;92(7):2153-2161. doi: 10.1007/s00204-018-2237-5. Epub 2018 Jun 6. Arch Toxicol. 2018. PMID: 29876591 Review.
-
Macrophages in necrotic liver lesion repair: opportunities for therapeutical applications.Am J Physiol Cell Physiol. 2024 May 1;326(5):C1556-C1562. doi: 10.1152/ajpcell.00053.2024. Epub 2024 Apr 15. Am J Physiol Cell Physiol. 2024. PMID: 38618702 Review.
Cited by
-
The Modulation of Phospho-Extracellular Signal-Regulated Kinase and Phospho-Protein Kinase B Signaling Pathways plus Activity of Macrophage-Stimulating Protein Contribute to the Protective Effect of Stachydrine on Acetaminophen-Induced Liver Injury.Int J Mol Sci. 2024 Jan 25;25(3):1484. doi: 10.3390/ijms25031484. Int J Mol Sci. 2024. PMID: 38338766 Free PMC article.
-
Nogo-B is a key mediator of hepatic ischemia and reperfusion injury.Redox Biol. 2020 Oct;37:101745. doi: 10.1016/j.redox.2020.101745. Epub 2020 Oct 8. Redox Biol. 2020. PMID: 33099216 Free PMC article.
-
Macrophage Depletion Impairs Skeletal Muscle Regeneration: the Roles of Pro-fibrotic Factors, Inflammation, and Oxidative Stress.Inflammation. 2016 Dec;39(6):2016-2028. doi: 10.1007/s10753-016-0438-8. Inflammation. 2016. PMID: 27605219
-
The Role of Monocytes and Macrophages in Acute and Acute-on-Chronic Liver Failure.Front Immunol. 2018 Dec 14;9:2948. doi: 10.3389/fimmu.2018.02948. eCollection 2018. Front Immunol. 2018. PMID: 30619308 Free PMC article. Review.
-
Gastrodin Alleviates Acetaminophen-Induced Liver Injury in a Mouse Model Through Inhibiting MAPK and Enhancing Nrf2 Pathways.Inflammation. 2022 Aug;45(4):1450-1462. doi: 10.1007/s10753-021-01557-1. Epub 2022 Apr 26. Inflammation. 2022. PMID: 35474551
References
-
- Hartleb M, Biernat L, Kochel A. Drug-induced liver damage—a three-year study of patients from one gastroenterological department. Med Sci Monit. 2002;8:CR292–CR296. - PubMed
-
- Lazarou J, Pomeranz B H, Corey P N. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA. 1998;279:1200–1205. - PubMed
-
- Lazerow S K, Abdi M S, Lewis J H. Drug-induced liver disease 2004. Curr Opin Gastroenterol. 2005;21:283–292. - PubMed
-
- Lee W M, Senior J R. Recognizing drug-induced liver injury: current problems, possible solutions. Toxicol Pathol. 2005;33:155–164. - PubMed
-
- Lee W M. Drug-induced hepatotoxicity. N Engl J Med. 2003;349:474–485. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases